Latest AI and machine learning research in hemophilia for healthcare professionals.
BACKGROUND AND PURPOSE: Microglia are central regulators of neuroinflammation in depression. Drivers...
The pseudoknot secondary structure in SARS-CoV-2 RNA is essential for regulating protein synthesis t...
RATIONALE: After inadequate response to first-line biologic or targeted synthetic (b/ts) disease-mod...
BACKGROUND: Inappropriate empirical antimicrobial therapy (IEAT) significantly increases mortality i...
Dual antiplatelet therapy (DAPT), combining aspirin with a P2Y12 inhibitor, remains central to secon...
BACKGROUND: Inherited PLN (phospholamban) R14del variants cause dilated cardiomyopathy with a high b...
Pyroptosis is a major contributor to the pathophysiology of acute liver failure (ALF), a condition w...
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with limited mechanism-based therapi...
BACKGROUND: A major challenge facing prostate cancer (PCa) cells is oxidative stress, yet the precis...
Poly(adenosine diphosphate-ribose) polymerase 1 (PARP1) is a pivotal target for treating homologous ...
Viral proteases are critical targets in antiviral drug development due to their essential role in th...
BACKGROUND: KRAS-mutant lung adenocarcinoma (LUAD) is associated with aggressive phenotypes and ther...
BACKGROUND: Postoperative nausea and vomiting (PONV) remains a prevalent complication hindering Enha...
Breast cancer is one of the most prevalent and lethal malignancies affecting women globally. The inc...
Vasculogenic mimicry (VM), a novel endothelial-independent blood perfusion pathway, is linked to adv...
Protein-protein interactions (PPIs) are shaped by evolutionary pressures that fine-tune binding affi...
CaMKIIα is a central regulator of synaptic plasticity and memory, and its pathological overactivatio...
BACKGROUND: Ferroptosis, a form of regulated cell death driven by iron-dependent lipid peroxidation,...
Backbone cyclization and disulfide bonding are key global covalent constraints in many bioactive pep...
BACKGROUND: ∼60%-70% of patients with metastatic non-small cell lung cancer (NSCLC) have relatively ...